Lack of Carboxyl Ester Lipase Increases HDL and Increases Reverse Cholesterol Transport in CETP Transgenic Mice

被引：0
|
作者：
Howles, Philip [1 ]
Camarota, Lisa [1 ]
Thornicroft, Jennifer [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2010年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E190 / E191
页数：2
相关论文
共 50 条
  • [31] Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver
    Bighetti, Eliete J. B.
    Patricio, Patricia R.
    Casquero, Andrea C.
    Berti, Jairo A.
    Oliveira, Helena C. F.
    LIPIDS IN HEALTH AND DISEASE, 2009, 8
  • [32] Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver
    Eliete JB Bighetti
    Patrícia R Patrício
    Andrea C Casquero
    Jairo A Berti
    Helena CF Oliveira
    Lipids in Health and Disease, 8
  • [33] Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice
    Tohyama, Junichiro
    Billheimer, Jeffrey T.
    Fuki, Ilia V.
    Rothblat, George H.
    Rader, Daniel J.
    Millar, John S.
    ATHEROSCLEROSIS, 2009, 204 (02) : 418 - 423
  • [34] Recombinant Human Lecithin-cholesterol Acyltransferase Treatment In Patients With ASCVD Increases HDL Through Increases In Cholesterol Ester Content.
    Reyes-Soffer, Gissette
    Matveyenko, Anastasiya
    Lignos, James
    Matienzo, Nelsa
    Baez, Leinys Santos
    Yung, Lau Y.
    Ramakrishnan, Rajasekhar
    George, Richard T.
    Ginsberg, Henry N.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41
  • [35] CETP Inhibitor Torcetrapib Improves the Severely Impaired Reverse Cholesterol Transport of Obese Insulin-Resistant CETP-apoB100 Transgenic Mice
    Briand, Francois
    Sulpice, Thierry
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E208 - E208
  • [36] Torcetrapib inhibits cholesterol ester transfer protein, atorvastatin decreases it and both increase HDL in APOE*3-Leiden.CETP transgenic mice
    Princen, HM
    de Haan, W
    van der Hoogt, CC
    van den Hoogen, CM
    Dallinga-Thie, GM
    Jukema, JW
    Havekes, LM
    Rensen, PC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E57 - E57
  • [37] rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment
    Maugeais, Cyrille
    Annema, Wijtske
    Blum, Denise
    Mary, Jean-Luc
    Tietge, Uwe J. F.
    ATHEROSCLEROSIS, 2013, 229 (01) : 94 - 101
  • [38] HUMAN LCAT OVEREXPRESSION IN TRANSGENIC MICE - EFFECT ON PLASMA HDL LEVELS AND POTENTIAL ROLE IN REVERSE CHOLESTEROL TRANSPORT
    VAISMAN, B
    KLEIN, HG
    BERARD, A
    ROUIS, M
    TALLEY, G
    MARCOVINA, S
    HOEG, JM
    HOYT, R
    BREWER, HB
    SANTAMARINAFOJO, S
    CIRCULATION, 1994, 90 (04) : 81 - 81
  • [39] Selective CETP Inhibition and PPARα Agonism Increase HDL Cholesterol and Reduce LDL Cholesterol in Human ApoB100/Human CETP Transgenic Mice
    Hansen, Michael K.
    McVey, Matthew J.
    White, Ray F.
    Legos, Jeffrey J.
    Brusq, Jean-Marie
    Grillot, Didier A.
    Issandou, Marc
    Barone, Frank C.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (02) : 196 - 202
  • [40] Fenofibrate increases HDL-cholesterol by reducing the expression of the cholesteryl ester transfer protein
    Van Der Hoogt, C. C.
    De Haan, W.
    Westerterp, M.
    Dallinga-Thie, G. M.
    Jukema, J. W.
    Havekes, L. M.
    Rensen, P. C. N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 560 - 561
12345